Work

Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a

Year: 2015

Type: article

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-015-3645-3

Authors: Adam R. Wolfe, Bisrat G. Debeb, Lara Lacerda, Richard Larson, Arvind Bambhroliya, Xuelin Huang, Francois Bertucci, Pascal Finetti, Daniel Birnbaum, Steven Van Laere, Parmeswaran Diagaradjan, Brian Ruffell, Nicholaus J. Trenton, Khoi Chu, Walter Hittelman, Michael Diehl, Ilya Levental, Naoto T. Ueno, Wendy A. Woodward

Institutions: The University of Texas MD Anderson Cancer Center, Institut Paoli-Calmettes, KU Leuven, Moffitt Cancer Center, Rice University, The University of Texas Health Science Center at Houston

Language: English

Topic: Cancer, Lipids, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Susan G. Komen for the Cure, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute, National Center for Advancing Translational Sciences

Awards: G111615301, (PQD4) SIGNS OF INFLAMMATORY BREAST CANCER ARE CAUSED BY STROMAL FIELD EFFECTS, G1468253849, G1901027039, G3131660374, G3457668292, G5015872367, G5644513130, G6581868571, G6736661663, Center for Clinical and Translational Sciences (CCTS), G8208765591, G9000273670, Cancer Center Support Grant

OpenAlex ID: W2285362178

FWCI: 1.57

Cites: 42

Cited by: 64

Related to: 10